Cat.#: ACPP-1821
| Despition | NT 4 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1485 | Rat VEGF C Protein (152 a.a.) (AC1485) | 2 µg | inquiry |
| ACPP-1495 | Cofilin Blocking Peptide (AC1495) | 250 µg | inquiry |
| ACPP-1744 | Human C1q Protein (AC1744) | 200 µg | inquiry |
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg | inquiry |
| ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
| ACPP-1034 | Recombinant Human NG2 Protein (6×His Tag) (AC1034) | 50 µg | inquiry |
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
| ACPP-1779 | Human HSD17B10 Protein (AC1779) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.